Location History:
- Frankfurt-am-Main, DE (2014)
- Hochheim, DE (2015)
Company Filing History:
Years Active: 2014-2015
Title: Christian Schoenau: Innovator in Kinase Inhibitors
Introduction
Christian Schoenau is a notable inventor based in Hochheim, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of kinase inhibitors. With a total of 2 patents to his name, Schoenau's work focuses on addressing diseases associated with diabetes and its complications.
Latest Patents
Schoenau's latest patents include innovative compounds that serve as kinase inhibitors. The first patent details substituted 6-(4-hydroxy-phenyl)-1H-pyrazolo[3,4-b]pyridine derivatives. These compounds are designed to treat diseases such as diabetic nephropathy, diabetic neuropathy, and diabetic retinopathy. The second patent involves 6-(4-hydroxy-phenyl)-3-alkyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives, which also function as kinase inhibitors for similar medical applications. Both inventions highlight the potential of these compounds as active ingredients in pharmaceuticals.
Career Highlights
Christian Schoenau is currently employed at Sanofi, a leading global healthcare company. His work at Sanofi has allowed him to focus on the development of innovative treatments that can significantly improve the quality of life for patients suffering from diabetes-related complications.
Collaborations
Schoenau collaborates with talented professionals in his field, including Stephanie Hachtel and Oliver Plettenburg. These collaborations enhance the research and development process, leading to more effective pharmaceutical solutions.
Conclusion
Christian Schoenau's contributions to the field of kinase inhibitors demonstrate his commitment to advancing medical science. His innovative patents and collaborations position him as a key figure in the fight against diabetes and its complications.